Document is current
Any future updates will be listed below
-
Authors
Jones, Daniel C. https://orcid.org/0000-0001-7055-3119
Elz, Anna E.
Hadadianpour, Azadeh
Ryu, Heeju
Glass, David R. https://orcid.org/0000-0001-9924-167X
Newell, Evan W. https://orcid.org/0000-0002-2889-243X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (P01 CA225517, U19AI128914, R01 CA264646)
- License Information
-
More Information
Article History
Received: 9 July 2024
Accepted: 9 April 2025
First Online: 22 May 2025
Competing interests
: E.W.N. is a co-founder, advisor and shareholder of ImmunoScape and is an advisor for Neogene Therapuetics and Nanostring Technologies. D.C.J. is listed as the inventor in a patent application for methods implemented in Proseg, submitted by the Fred Hutchinson Cancer Center. The other authors declare no competing interests.
